Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Free Subscription


3 Am J Hematol
3 Ann Hematol
3 Blood
1 BMC Cancer
3 Bone Marrow Transplant
2 Br J Haematol
1 Cancer Chemother Pharmacol
3 Int J Hematol
1 J Pediatr Hematol Oncol
4 Leuk Lymphoma
3 Leuk Res
3 Leukemia
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Hematol

  1. HASTINGS A, Apperley JF, Nadal-Melsio E, Brown L, et al
    Acute myeloid leukemia with a severe coagulopathy and t(8;16)(p11;p13).
    Am J Hematol. 2020 Jun 10. doi: 10.1002/ajh.25903.

  2. JAIN P, Wang XI
    Carcinocythemia - cancer cell leukemia.
    Am J Hematol. 2020 Jun 10. doi: 10.1002/ajh.25902.

  3. SAMRA B, Alotaibi AS, Short NJ, Khoury JD, et al
    Outcome of adults with relapsed/refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
    Am J Hematol. 2020 Jun 5. doi: 10.1002/ajh.25896.

    Ann Hematol

  4. STEMLER J, Koehler P, Maurer C, Muller C, et al
    Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma.
    Ann Hematol. 2020 Jun 8. pii: 10.1007/s00277-020-04107.
    PubMed         Abstract available

  5. YANAGISAWA H, Mizuta S, Kawabata H, Fujimoto S, et al
    Faggot cells in acute myeloid leukemia with t(7;11)(p15;p15) and NUP98-HOXA9 fusion.
    Ann Hematol. 2020 Jun 8. pii: 10.1007/s00277-020-04122.

  6. BECKER H, Pfeifer D, Ihorst G, Pantic M, et al
    Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.
    Ann Hematol. 2020 Jun 6. pii: 10.1007/s00277-020-04082.
    PubMed         Abstract available


    ON TRacK towards novel targets in leukemia.
    Blood. 2020;135:2117-2119.

  8. PATEL K, Isufi I, Kothari S, Davidoff AJ, et al
    Cost-Effectiveness of First-Line Ibrutinib versus Third-Line in Patients with Untreated Chronic Lymphocytic Leukemia.
    Blood. 2020 Jun 9. pii: 460741. doi: 10.1182/blood.2020004922.
    PubMed         Abstract available

  9. DIRAL E, Mori S, Antolini L, Abruzzese E, et al
    Increased tumor burden in Chronic Myeloid Leukemia patients after 36 months of imatinib discontinuation.
    Blood. 2020 Jun 9. pii: 460734. doi: 10.1182/blood.2019004371.

    BMC Cancer

  10. HLOZKOVA K, Pecinova A, Alquezar-Artieda N, Pajuelo-Reguera D, et al
    Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase.
    BMC Cancer. 2020;20:526.
    PubMed         Abstract available

    Bone Marrow Transplant

  11. BRISSOT E, Labopin M, Baron F, Bazarbachi A, et al
    Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2020 Jun 11. pii: 10.1038/s41409-020-0970.

  12. VAN ENS D, Mousset CM, Hutten TJA, van der Waart AB, et al
    PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity.
    Bone Marrow Transplant. 2020 Jun 11. pii: 10.1038/s41409-020-0966.
    PubMed         Abstract available

  13. NUNEZ-TORRON C, Garcia-Gutierrez V, Tenorio-Nunez MC, Moreno-Jimenez G, et al
    Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19.
    Bone Marrow Transplant. 2020 Jun 4. pii: 10.1038/s41409-020-0961.

    Br J Haematol

  14. ABRISQUETA P, Delgado J, Alcoceba M, Oliveira AC, et al
    Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC).
    Br J Haematol. 2020 Jun 9. doi: 10.1111/bjh.16748.
    PubMed         Abstract available

  15. BATALLER A, Onate G, Diaz-Beya M, Guijarro F, et al
    Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.
    Br J Haematol. 2020 Jun 8. doi: 10.1111/bjh.16857.
    PubMed         Abstract available

    Cancer Chemother Pharmacol

  16. LARSEN RH, Hjalgrim LL, Grell K, Kristensen K, et al
    Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2020 Jun 9. pii: 10.1007/s00280-020-04097.
    PubMed         Abstract available

    Int J Hematol

  17. HENZAN H, Takase K, Kamimura T, Mori Y, et al
    Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
    Int J Hematol. 2020 Jun 10. pii: 10.1007/s12185-020-02911.
    PubMed         Abstract available

  18. LUCIJANIC M, Krecak I
    Effect of age and comorbidities on the decline of glomerular filtration rate in chronic myeloid leukemia patients discontinuing tyrosine kinase inhibitors.
    Int J Hematol. 2020 Jun 9. pii: 10.1007/s12185-020-02915.

  19. KANAYA M, Kondo T
    Diffuse alveolar hemorrhage during induction therapy for acute myeloid leukemia with inv(16)(p13.1q22).
    Int J Hematol. 2020 Jun 6. pii: 10.1007/s12185-020-02900.

    J Pediatr Hematol Oncol

  20. NIRMAL G, Thankamony P, Chellapam Sojamani G, Nair M, et al
    Prevalence and Risk Factors for Metabolic Syndrome Among Childhood Acute Lymphoblastic Leukemia Survivors: Experience From South India.
    J Pediatr Hematol Oncol. 2020 Jun 8. doi: 10.1097/MPH.0000000000001856.
    PubMed         Abstract available

    Leuk Lymphoma

  21. TAVITIAN S, Uzunov M, Berard E, Bouscary D, et al
    Ponatinib-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the real-life OPAL study.
    Leuk Lymphoma. 2020 Jun 8:1-7. doi: 10.1080/10428194.2020.1762876.
    PubMed         Abstract available

  22. PLEYER C, Sun C, Desai S, Ahn IE, et al
    Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors.
    Leuk Lymphoma. 2020 Jun 6:1-8. doi: 10.1080/10428194.2020.1772477.
    PubMed         Abstract available

  23. PAGANI IS, Dang P, Saunders VA, Braley J, et al
    Clinical utility of genomic DNA Q-PCR for the monitoring of a patient with atypical e19a2 BCR-ABL1 transcripts in chronic myeloid leukemia.
    Leuk Lymphoma. 2020 Jun 6:1-3. doi: 10.1080/10428194.2020.1772476.

  24. FREI M, Aitken SL, Jain N, Thompson P, et al
    Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinib.
    Leuk Lymphoma. 2020 Jun 12:1-4. doi: 10.1080/10428194.2020.1775215.

    Leuk Res

  25. O'CONNOR-BYRNE N, Quinn J, Glavey SV, Lavin M, et al
    Venetoclax for chronic lymphocytic leukemia associated immune thrombocytopenia following recovery from progressive multifocal leukoencephalopathy.
    Leuk Res. 2020;95:106390.

  26. GOLDBERG AD, Atallah E, Rizzieri D, Walter RB, et al
    Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study.
    Leuk Res. 2020;95:106385.
    PubMed         Abstract available

  27. AGUILERA-DIAZ A, Larrayoz MJ, Palomino-Echeverria S, Vazquez I, et al
    Strategy for identification of a potential inherited leukemia predisposition in a 299 patient's cohort with tumor-only sequencing data.
    Leuk Res. 2020;95:106386.
    PubMed         Abstract available


  28. WONG RL, Ketcham M, Irwin T, Akilesh S, et al
    Donor-derived acute promyelocytic leukemia presenting as myeloid sarcoma in a transplanted kidney.
    Leukemia. 2020 Jun 10. pii: 10.1038/s41375-020-0903.

  29. NORSWORTHY KJ, Avagyan A, Bird ST, Li Y, et al
    Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis.
    Leukemia. 2020 Jun 9. pii: 10.1038/s41375-020-0905.

  30. ECTOR GICG, Visser O, Westerweel PE, Janssen JJWM, et al
    Primary therapy and relative survival among elderly patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989-2017.
    Leukemia. 2020 Jun 8. pii: 10.1038/s41375-020-0902.

    Proc Natl Acad Sci U S A

  31. LAMBLE AJ, Kosaka Y, Laderas T, Maffit A, et al
    Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2020 Jun 8. pii: 1916206117.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.